Early urodynamic effects of the lipido-sterolic extract of Serenoa repens (Permixon®) in patients with lower urinary tract symptoms due to benign prostatic hyperplasia
被引:0
作者:
SH Al-Shukri
论文数: 0引用数: 0
h-index: 0
机构:Pavlov State Medical University,Department of Urology
SH Al-Shukri
P Deschaseaux
论文数: 0引用数: 0
h-index: 0
机构:Pavlov State Medical University,Department of Urology
P Deschaseaux
IV Kuzmin
论文数: 0引用数: 0
h-index: 0
机构:Pavlov State Medical University,Department of Urology
IV Kuzmin
RR Amdiy
论文数: 0引用数: 0
h-index: 0
机构:Pavlov State Medical University,Department of Urology
RR Amdiy
机构:
[1] Pavlov State Medical University,Department of Urology
[2] Pierre Fabre Médicament,undefined
[3] Parc Industriel de la Chartreuse,undefined
来源:
Prostate Cancer and Prostatic Diseases
|
2000年
/
3卷
关键词:
urodynamics;
benign prostatic hyperplasia;
medical treatment;
Permixon®;
infravesical obstruction;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
This prospective, controlled study was undertaken to evaluate the early urodynamic and symptomatic impact of the lipido-sterolic extract of Serenoa repens (Permixon® ) in the treatment of patients with benign prostatic hyperplasia (BPH).